Verrica Pharmaceuticals Inc. Shares Outstanding (Cover Page)
Verrica Pharmaceuticals Inc. (VRCA) had Shares Outstanding (Cover Page) of 17.18 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 17.18M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 17.18M shares.
- 2026-03-02: Entity Common Stock, Shares Outstanding 17.18M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 9.49M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 17.18M shares 10-Q · filed 2026-08-06 |
| 2026-05-05 | 17.18M shares 10-Q · filed 2026-05-12 |
| 2026-03-02 | 17.18M shares 10-K · filed 2026-03-11 |
| 2025-11-07 | 9.49M shares 10-Q · filed 2025-11-14 |
| 2025-08-05 | 9.45M shares 10-Q · filed 2025-08-12 |
| 2025-05-07 | 92.49M shares 10-Q · filed 2025-05-13 |
| 2025-03-05 | 91.78M shares 10-K · filed 2025-03-11 |
| 2024-10-28 | 45.60M shares 10-Q · filed 2024-11-05 |
| 2024-08-08 | 42.67M shares 10-Q · filed 2024-08-14 |
| 2024-05-07 | 42.42M shares 10-Q · filed 2024-05-13 |
| 2024-02-23 | 42.42M shares 10-K · filed 2024-02-29 |
| 2023-11-03 | 42.06M shares 10-Q · filed 2023-11-09 |
| 2023-08-01 | 42.06M shares 10-Q · filed 2023-08-08 |
| 2023-05-03 | 41.96M shares 10-Q · filed 2023-05-09 |
| 2023-03-01 | 41.85M shares 10-K · filed 2023-03-06 |
| 2022-11-02 | 41.09M shares 10-Q · filed 2022-11-07 |
| 2022-08-05 | 41.09M shares 10-Q · filed 2022-08-11 |
| 2022-05-02 | 27.52M shares 10-Q · filed 2022-05-09 |
| 2022-02-24 | 27.52M shares 10-K · filed 2022-03-02 |
| 2021-11-03 | 27.52M shares 10-Q · filed 2021-11-12 |
| 2021-08-02 | 27.51M shares 10-Q · filed 2021-08-10 |
| 2021-05-03 | 27.41M shares 10-Q · filed 2021-05-07 |
| 2021-03-15 | 25.44M shares 10-K · filed 2021-03-17 |
| 2020-11-05 | 25.87M shares 10-Q · filed 2020-11-09 |
| 2020-07-30 | 25.81M shares 10-Q · filed 2020-08-05 |
| 2020-05-04 | 25.81M shares 10-Q · filed 2020-05-07 |
| 2020-03-06 | 25.81M shares 10-K · filed 2020-03-13 |
| 2019-11-01 | 25.78M shares 10-Q · filed 2019-11-06 |
| 2019-08-05 | 25.74M shares 10-Q · filed 2019-08-07 |
| 2019-05-03 | 25.71M shares 10-Q · filed 2019-05-07 |
| 2019-03-04 | 25.71M shares 10-K · filed 2019-03-07 |
| 2018-11-02 | 25.70M shares 10-Q · filed 2018-11-07 |
| 2018-08-07 | 25.70M shares 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |